Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hereditary angioedema
Research
Poseida gene therapy reduces kallikrein protein levels in mice
At the minimally effective dose of 0.125 milligrams per kilogram, kallikrein levels were reduced in the mouse model by 58%, the company said.
Darren Incorvaia
Oct 24, 2024 1:20pm
Intellia links in vivo CRISPR therapy to 81% drop in HAE attacks
Oct 24, 2024 8:55am
Pharming uproots angioedema gene therapy collab with Orchard
May 8, 2024 6:15am
With new data in hand, Astria makes ph. 3 wish on shooting star
Mar 25, 2024 10:46am
KalVista's persistence with sebetralstat pays off in ph. 3 win
Feb 13, 2024 6:30am
Ionis’ HAE drug wins in phase 3 setting up approval run to FDA
Jan 22, 2024 9:34am
